Magle Chemoswed Holding AB (publ) (FRA:52X)

Germany · Delayed Price · Currency is EUR

0.9600

+0.0050 (0.52%)

At close: Jan 29, 2026

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Royalties, Licenses, etc.	73.07M
Royalties, Licenses, etc. Growth	87.38%
Services	62.77M
Services Growth	12.45%
Active Pharmaceutical Ingredients	54.90M
Active Pharmaceutical Ingredients Growth	-18.03%
Internal Eliminations	-20.30M
Internal Eliminations Growth	26.01%
Internal Eliminations	-20.30M
Internal Eliminations Growth	26.01%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Internal Eliminations	-20.30M
Internal Eliminations Growth	26.01%
European Union excluding Sweden	49.24M
European Union excluding Sweden Growth	-21.57%
Sweden	48.37M
Sweden Growth	68.21%
Internal Eliminations	-20.30M
Internal Eliminations Growth	26.01%
Other	93.14M
Other Growth	32.57%